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Abstract 
Controversy regarding Human embryonic Stem Cell (hESC) research is evident in the medical and 
scientific community, legislative, judicial, and executive branches of the government, private 
companies, religious affiliations, special interest groups, and among the general American public. 
Stem cells are derived from adult stem cell resources, which are termed non-embryonic or from the 
cells of immature blastocysts termed embryonic stem cells. Non-embryonic cells do not have the 
ability to differentiate into other specialized tissues, whereas embryonic cells are capable of 
differentiating into almost any type of tissue. hESC research, which is the focus of this paper, 
includes the direct creation and therapeutic cloning of human embryos, known as somatic cell 
nuclear transfer (SCNT) during the blastocyst-stage of development, the use of surplus embryos 
from in vitro fertilization, and from tissue derived from extracted embryos through abortion. The 
purpose of hESC research is threefold: (1) to advance science and medicine, (2) prevent disease, 
and (3) cure certain diseases. hESC research is an ethical dilemma facing the United States of 
America. Opponents of hESC often cite the rights of the embryo and define the embryo at 
conception. Supporters of hESC research include the scientific and medical community, and 
private hESC research companies. The unique political system of the United States has allowed for 
a dichotomous policy to arise, where federal funding of hESC is prohibited, but private companies 
and individual states are able to legally forge a path in hESC research. The prohibition of federal 
funds has created an abyss between states who choose to fund hESC research and those who 
prohibit it. It has also set the stage for yet another private corporation to advance in hESC and 
place profit above the American public. The embryo is the only silent member of this debate. 
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Controversy regarding Human embryonic Stem Cell (hESC) research is evident in the medical and 
scientific community, legislative, judicial, and executive branches of the government, private companies, 
religious affiliations, special interest groups, and among the general American public .   Stem cells are derived 
from adult stem cell resources, which are termed “non-embryonic” or from the cells of immature blastocysts 
termed “embryonic” stem cells1.   Non-embryonic cells do not have the ability to differentiate into other 
specialized tissues, whereas embryonic cells are capable of differentiating into almost any type of tissue.
2
  hESC 
research, which is the focus of this paper, includes the direct creation and “therapeutic cloning” of human 
embryos, known as somatic cell nuclear transfer (SCNT) 
3
  during the blastocyst-stage of development,
4
  the use 
of surplus embryos from in vitro fertilization
5
, and from tissue derived from extracted embryos through 
abortion.  The purpose of hESC research is threefold:  (1) to advance science and medicine, (2) prevent disease, 
and (3) cure certain diseases.   The most useful type of stem cell is the “pluripotent stem cell” and is derived 
directly from the blastocyst during the five to seven days after fertilization
6
.   This limited time period for 
optimization of hESC research suggests a greater need for SCNT to provide embryos specific to this stage of 
development for optimal differentiation of tissues.  Others continue to argue that “we simply do not know which 
type of stem cell research is the most promising”.  The opposition argument often refers to the unique problems 
related to pluripotent embryonic stem cell development, including the probability of forming certain prolific 
tumors due to uncontrolled cell division
7
 
Early 20
th
 century American medical controversies centered on eugenics, birth control, population 
control, and planned reproduction
8
.   Similar reproductive themes including hESC and cloning, one century 
later, have erupted in American society.   The majority of the American public agrees that human cloning for 
reproductive purposes should be banned.  However, the debate regarding the use of cloned embryos for research 
purposes remains volatile.  Religious ethicists provide arguments according to moral motivation and guidance. 
Catholic religious ethicists argue against hESC research based on grounds of “murder of the embryo”.   Judaism 
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presents a more complex and rich argument with exceptions allowed for in vitro fertilization embryos, tissue 
extracted from abortive fetuses already destined for destruction, and “therapeutic cloning” based on the 
embryos decreased status when outside the womb.
9
  The Islamic viewpoint is not as clear with some siding with 
the Catholic stance on hESC research and other scholars quoting a termination date of 56 days post fertilization 
as the acceptable period for extraction processes.
1011
   Many religious and secular opponents to hESC research 
fear this type of “therapeutic cloning” will be used in future generations for actual cloning of human beings.12   
An example of this perspective is reflected in the Weldon Bill, which proposed criminalization of all cloning, 
including “therapeutic cloning”.13  Secular opponents including women’s rights groups also oppose the 
harvesting of eggs for hESC to respect the  autonomy and true voluntary consent of women, acknowledging the 
possibility of coercion of women from poor socio-economic backgrounds for egg harvesting procedures.   
At the other end of the spectrum is the scientific community who view hESC through a utilitarian lens 
where the ends (cure of disease through hESC) is used to justifies the means of “human cloning”.  Some view 
hESC as leading to the repetition of historical atrocities and cite examples from World War II theories of 
attaining a “perfect race”, experimentation with genetic alteration, and unnatural population control method.  In 
a fictitious worst case scenario, The Boys from Brazil, referred to by Korobkin, is a novel from the 1970s which 
highlights the negative aspect of embryonic stem cell research possibilities where cloning falls into the “wrong 
hands” and the very real historical Nazi concentration camp scientist, Josef Mengele,  makes several clones of 
Adolph Hitler
14
.   Other rule utilitarian approaches consider hESC research as opportunity for the advancement 
of women, autonomous decision making in a complex male dominated society,  and to choose the perfect 
qualities for future generations, free of disease.  They cite specific rules that, if endorsed, would protect the 
public from extreme measures of research, including reproductive human cloning
15
.    
In 2001, serious concerns about the ethics of embryonic stem cell research as they relate to values of 
respect for human dignity, informed consent related to donors, possibility of financial coercion and 
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manipulation of donors were raised by Chair of the President’s Council on Human Bioethics, Dr. Leon Kass16.    
The main ethical question considered among the research regarding hESC can be posed in four main questions.  
What do we owe to developing human life?  What do we owe to science and the possible alleviation of human 
suffering and disease by using hESC research? What rights does the embryo have?  What rights do the people 
have in relationship to furthering science for alleviation of human suffering?   
 In 1975, a federal rule was enacted that disallowed for any research to be done on in vitro fertilization 
products until reviewed and accepted by the Ethics Advisory Board (EAB).  This appeared to be an early 
attempt to acknowledge the “potentiality of autonomy” of the embryo and right to respect and dignity.  The rule 
was directed toward embryos resulting directly from in vitro fertilization and may have also been a reaction to 
protect abortive embryos from scientific experimentation from the 1973 Roe Vs Wade ruling.  However, in 
1979, the EAB gave the approval to fund embryonic research under certain circumstances.   In 1980, the federal 
rule remained in place that required the EAB to approve all funding for hESC, however the EAB’s charter 
expired, leaving a “defacto moratorium” on embryonic stem cell research.  This problem was soon resolved 
when President Clinton, in 1993, reminded the public of the rights of society to advance medical treatments that 
would benefit society and rescinded the rule that required EAB approval and allowed for HESC research to 
resume. 
17
  
In 1996, the Dickey Amendment was passed with the “Department of Labor, Health, Human Services, 
Education, and Related Agencies Act”, which again discontinued federal funding of hESC.   The battle 
continued regarding federal funding of hESC, however, when the Dickey Amendment was interpreted narrowly 
to allow federal funding but only on “private hESC research lines”.18   The rule disallowing federal funds to be 
placed toward hESC research while private companies are able to legally advance hESC through silent policy of 
the government is a product of our pluralist governmental system.   Religious ethics regarding “embryo dignity” 
have been tested against those who hold a form of prima facie duties perspective where “exceptions, when they 
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conflict with other duties, have greater importance in a given situation”19   Some also argue, from a Kant duty 
ethicist perspective, whether embryos that have the potential for rationality, but are not, in essence, rational 
human beings at the blastocyst stage, be considered “rational” for purposes of protection. 
 In August 2001, President Bush, seemingly supporting a  rights ethicist viewpoint in regards to human 
embryos, stated that “human embryonic stem cell research is morally wrong” and proclaimed that he would not 
fund any hESC research lines created after August 9, 2001.
20
    President Bush, however, has been criticized for 
inconsistency in his argument regarding hESC funding and the failure to halt any private research on hESC as 
well as the presidential endorsement and funding of contrary policies regarding fundamental value of adult 
human life in issues surrounding the Iraq War, Guantanamo Bay, the “acceptable” use of torture, and failure to 
provide adequate aide to Hurricane Katrina victims during his presidency.
21
   
Shortly after the presidential ban on hESC research, Congress considered a ban on human cloning 
altogether.  However, this failed to materialize  because of the difficulties arising from problematic terminology 
restricting “all cloning” which could lead to restrict even therapeutic adult cell tissue “splicing” of tissue from 
individuals with disease for regeneration of healthy tissue.
22
   Those in favor of a cloning ban included the 
United Sates Conference of Catholic Bishops, The Family Research Council, and the Methodist Church.   The 
banning of cloning has been described by religious and secular communities in terms of “negative immortality”, 
the continual regeneration and preservation of life at all costs, as opposed to “positive immortality”, the belief 
that extending one’s own life is not as desirable as leading a good life.23   Some bioethicists have raised 
distinctive concerns termed the “created-discarded” ethics of allowing for embryos “slated for destruction” to be 
saved for hESC, but not accepting those lines of hESC which would promote creation of more embryos than 
necessary solely for research purposes.
24
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The National Organ Transplant Act (NOTA) enacted in 1984 prohibits the sale of tissues, with the 
exception of blood and sperm, for purposes of transplantation, but not for research purposes.  In 2005, the 
National Research Council (NRC) provided guidelines for the scientific community for research directly related 
to human embryonic stem cell research. The National Institute of Health, the American Academy of Pediatrics, 
and the state of California have adopted similar laws for donors.   Guidelines recommended no payment to the 
donors of embryonic stem cell lines with intentions to reduce the probability of unethical coercion of the 
subjects and possible persuasion to create more IVF embryos than needed for fertilization for purpose of sale, 
increase the altruistic nature of the applicants who donate, and maintains human dignity.
25
    
In 2006, the House and Senate passed the Stem Cell Research Enhancement Act to allow federal 
funding of hESC; however, the bill was quickly vetoed by President Bush and the House was unable to override 
the veto.
26
  Despite the controversy over legal issues involving human embryonic stem cell research and the 
prohibition on funding hESC lines after August 2001, currently no law prohibits hESC research in the United 
States.
27
   Judicial influences have traditionally upheld due process in the law making process and have found 
unenumerated rights to be a part of substantive due process.  Supporters of hESC have argued that a ban on 
hESC would deny Fifth and Fourteenth Amendment rights of life and liberty to have safe and effective medical 
treatments that allow people to be free of pain and disability.
28
   
 States have become directly involved in funding human stem cell research, with funding strictly 
prohibited in only thirteen states but many other states taking advantage of the laxity in federal law and raising 
funds specifically for hESC research.  California’s Proposition 71 in 2004 was the first of the state endeavors 
that raised approximately 3.3 billion dollars to promote human embryonic stem cell research in conjunction 
with a private biotechnology company
29
.   Other states soon followed suit to begin partnerships with universities 
and private companies for promotion of embryonic stem cell research.   
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This rift between the federal law on one side and the majority of states and companies on the other 
begins to create an imbalance and potential problem for the American public who may not be involved in the 
biotechnological advances once they are marketed within the health care arena.  Private companies who tend to 
profit from such ventures and create treatments for the wealthy, would be at a great competitive advantage to a 
government and some states that have refused to fund any hESC beyond the original August 2001 deadline.   
Distributive justice is breeched when access to health care involving hESC research will be limited for the 
general public, the socioeconomically disadvantaged, and those who live in states who do not support this type 
of research or treatment.  Distributive justice must also include the “embryonic” tissue, which calls into 
question the actual definition of a five to seven day old blastocyst and the moral obligation of the 
embryo/blastocyst at stake.  Terminology has traditionally termed the cells in order from conception as 
blastocyst, zygote, embryo, and fetus by the scientific community.  However, recent terminology changes 
initiated in science textbooks across the country by pro-life groups with primarily protestant and Catholic 
religious roots, have reflected the often debated subject by creating only one term the “embryo” to describe all 
stages prior to the “fetus”.    This provides for a legal and ethical background to support the ban on hESC 
research at any level of development as a “basic right” of the embryo.30    
In conclusion, hESC research is an ethical dilemma facing the United States of America.  Opponents of 
hESC often cite the “rights” of the embryo and define the embryo at conception.  Supporters of hESC research 
include the scientific and medical community, and private hESC research companies.  From a utilitarian 
perspective, they also cite “rights”, but refer to the rights of the adults who need advancement in medical care 
and cures for current debilitating diseases and do not consider a 5-7 day old blastocyst as more than cellular 
mass to be used in research purposes.  The unique political system of the United States has allowed for a 
dichotomous policy to arise, where federal funding of hESC is prohibited, but private companies and individual 
states are able to legally forge a path in hESC research.  The prohibition of federal funds has created an abyss 
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between states who choose to fund hESC research and those who prohibit it.  It has also set the stage for yet 
another private corporation to advance in hESC and place profit above the American public.  The embryo is the 
only silent member of this debate. 
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